Biological control program - phase I DARPA anticipates that the biological control program will provide predictive, closed-loop, generalizable means for controlling various biological systems and…
Ended Definitive Contract Awarded Last action
- Contract number
- HR001116C0139
- Awardee
-
The Johns Hopkins University UEI FTMTDMBR29C7
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $5,937,885
Award facts
- Opportunity
-
- Biological Control Award Notice · Posted Sep 27, 2016
- Contract value 100% obligated
- $5,937,885.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 20 offers Basic Research
- Pricing
- Cost No Fee
- Place of performance
- Baltimore, MD 21218, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $228,183 | |
| Supplemental Agreement for work within scope | $450,000 | |
| Exercise an Option | $145,396 | |
| Supplemental Agreement for work within scope | $240,482 | |
| Funding Only Action | $944,875 | |
| Supplemental Agreement for work within scope | $474,225 | |
| Exercise an Option | $1,000,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $1,636,483 | |
| Original award | $818,241 |
Show all 12
About this award
This is a definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to The Johns Hopkins University, a private non-profit research university, for the Biological Control Program - Phase I. The contract is valued at $5,937,885.00 and does not utilize any set-aside designations.
The Biological Control Program aims to provide predictive, closed-loop, and generalizable means for controlling various biological systems and programming diverse system-level behaviors across multiple scales. As a leading academic institution, The Johns Hopkins University has a strong track record of supporting critical national initiatives through cutting-edge scientific research, advanced technological development, and comprehensive interdisciplinary expertise.
The contract has a period of performance ending on March 31, 2021. The university has also been awarded an Indefinite Delivery Contract (IDV) with the National Heart, Lung, and Blood Institute for the Multi-Ethnic Study of Atherosclerosis (MESA) program, valued at $55.55 million, demonstrating its strategic importance as a long-term federal research partner.
Description
Biological control program - phase I DARPA anticipates that the biological control program will provide predictive, closed-loop, generalizable means for controlling various biological systems and programming diverse system level behaviors across multiple scales.
Quick answers
Who was awarded contract HR001116C0139?
HR001116C0139 was awarded to The Johns Hopkins University by Defense Advanced Research Projects Agency (Department of Defense) on September 23, 2016.
How much is contract HR001116C0139 worth?
The government has obligated $5,937,885 on HR001116C0139.
Was contract HR001116C0139 competed?
The extent of competition for HR001116C0139 was full and open competition. The government received 20 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award